Additionally, we explored TCGA data and analyzed the correlation between C3aR1+PDGFA+ expression and the survival of triple negative breast cancer patients, we found that patients with a high level of C3aR1+PDGFA+ expression had a poorer survival rate (Fig. 6g). This evidence concerns the gene PDGFA and triple-negative breast carcinoma.